Transdisciplinary Seminar, Institute for Frontier Science Initiative: Research on the Development of Anti-Cancer Drugs Utilizing Genomic Information and Chemical Biology

登録日:2025-10-27
Open to public
Date and Time
December 12, 2025, 4:00 p.m. - 5:00 p.m.
Place
Conference Room, 4th Floor, Cancer Research Institute, Kakuma Campus, Kanazawa University
Event Details

[Title] Research on the Development of Anti-Cancer Drugs Utilizing Genomic Information and Chemical Biology
[Speaker] Associate Professor Kiyoshi Yamaguchi (Division of Clinical Genome Research, Institute of Medical Science, The University of Tokyo)

We will hold a transdisciplinary seminar on research on the development of anti-cancer drugs utilizing genomic information and chemical biology.

Protein acetylation is one of the representative mechanisms of epigenetic regulation. The bromodomain is a functional domain that plays a key role in recognizing acetylated lysine residues, and it is involved in DNA-dependent cellular processes such as transcription and chromatin remodeling.

In this seminar, we will discuss the potential for developing anti-cancer drugs targeting bromodomains. We will also introduce specialized sequencing technologies that are useful in the field of chemical biology.

We look forward to your participation.

[Location]

Click here for the map of Kanazawa University Kakuma Campus

How to attend
No registration is required. Please come directly to the venue on the day of the seminar.
attachment
Contact

Assistant Professor Yasuhiro Nakano (Integrated Systems of Aging Research Unit, Institute for Frontier Science Initiative / Division of Cancer and Aging Biology, Cancer Research Institute)  TEL: 076-234-4520

FacebookPAGE TOP